Get the Stockscreener App
1.21
5.47%
-0.07
After Hours:
1.17
-0.04
-3.31%
Werewolf Therapeutics Inc Stock (HOWL) Forecast
The Werewolf Therapeutics Inc (HOWL) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.8763, representing a -27.58% decrease from the current price of $1.21. The highest analyst price target is $0.776, and the lowest is $0.9767.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HOWL Price Target
Average 2.3005
(+90.12% Upside)
Is Werewolf Therapeutics Inc (HOWL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.51 | Neutral |
| STOCH(9,6) | 74.79 | Neutral |
| STOCHRSI(14) | 48.37 | Neutral |
| MACD(12,26) | 0.081 | Buy |
| ADX(14) | 32.84 | Buy |
| William %R | -20.41 | Neutral |
| CCI(14) | 56.61 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.161
Buy
|
1.1587
Buy
|
| MA20 |
1.0552
Buy
|
1.0853
Buy
|
| MA50 |
0.9489
Buy
|
1.051
Buy
|
| MA100 |
1.1425
Buy
|
1.2194
Sell
|
| MA200 |
1.6081
Sell
|
1.8887
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, HOWL could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 3 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on HOWL, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 62.51 indicates that HOWL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 74.79 indicates that HOWL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 48.37 indicates that HOWL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.84 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 56.61 indicates that HOWL is still overbought but not to an extreme extent.
Long-term HOWL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Werewolf Therapeutics Inc financial reports and earnings history, Werewolf Therapeutics Inc (HOWL) stock could reach $6.3868 by 2030, $35.15 by 2040 and $60.11 by 2050. See the projected annual prices until 2050 of the Werewolf Therapeutics Inc stock below:
- Werewolf Therapeutics Inc (HOWL) is expected to reach an average price of $21.03 in 2035, with a high prediction of $20.01 and a low estimate of $19.00. This indicates an $1,638% rise from the last recorded price of $1.21.
- Werewolf Therapeutics Inc (HOWL) stock is projected to chart a bullish course in 2040, with an average price target of $36.08, representing an $2,882% surge from its current level. The forecast ranges from a conservative $11.66 to a sky-high $35.15.
- Our analysts predict Werewolf Therapeutics Inc (HOWL) to jump 2,890% by 2045, soaring from $36.55 to an average price of $36.18, potentially reaching $36.25. While $36.55 is the low estimate, the potential upside is significant.
- Werewolf Therapeutics Inc (HOWL) stock is expected to climb by 2050, reaching an average of $60.87, a $4,930% jump from its current level. However, a wide range of estimates exists, with high and low targets of $60.11 and $59.76, respectively, highlighting the market's uncertainty.
Werewolf Therapeutics Inc Stock (HOWL) Year by Year Forecast
Werewolf Therapeutics Inc Stock (HOWL) Price Forecast for 2025
Werewolf Therapeutics Inc Stock (HOWL) is expected to reach an average price of $2.3005 in 2025, with a high prediction of $4.175 and a low estimate of $0.4259. This indicates an +90.12% rise from the last recorded price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.426 | $0.9767 | $0.776 | -64.79% |
| August, 2025 | $1.8743 | $0.4259 | $1.0359 | +54.90% |
| September, 2025 | $3.2845 | $2.2543 | $2.5395 | +171.45% |
| October, 2025 | $4.2948 | $3.4646 | $4.1248 | +254.94% |
| November, 2025 | $4.1351 | $4.2551 | $4.175 | +241.74% |
| December, 2025 | $1.5454 | $2.7853 | $4.0314 | +27.72% |
Werewolf Therapeutics Inc Stock (HOWL) Price Forecast for 2026
The predicted value for Werewolf Therapeutics Inc (HOWL) in 2026 is set at an average of $2.4107. Estimates vary from a peak of $2.9562 to a trough of $1.8651, indicating an +99.23% surge from the present price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.3056 | $2.1055 | $1.7256 | +90.55% |
| February, 2026 | $2.9259 | $2.4957 | $2.5359 | +141.81% |
| March, 2026 | $2.8861 | $3.2003 | $2.9562 | +138.52% |
| April, 2026 | $2.3565 | $2.9762 | $2.8974 | +94.75% |
| May, 2026 | $2.0267 | $2.3467 | $2.3466 | +67.50% |
| June, 2026 | $2.277 | $1.9268 | $1.667 | +88.18% |
| July, 2026 | $2.2173 | $1.8651 | $1.967 | +83.25% |
| August, 2026 | $2.3175 | $2.3173 | $2.1725 | +91.53% |
| September, 2026 | $2.1078 | $2.0476 | $2.0478 | +74.20% |
| October, 2026 | $2.2481 | $2.5279 | $2.368 | +85.79% |
| November, 2026 | $1.2683 | $2.1283 | $1.9981 | +4.82% |
| December, 2026 | $1.7386 | $1.9086 | $2.0084 | +43.69% |
Werewolf Therapeutics Inc Stock (HOWL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Werewolf Therapeutics Inc (HOWL) is $3.1517, with a high forecast of $6.2333 and a low forecast of $0.0702. This indicates an +160.47% increase from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3089 | $1.0889 | $1.2887 | -74.47% |
| February, 2027 | $0.3009 | $0.0909 | $1.451 | -75.14% |
| March, 2027 | $3.4905 | $0.1907 | $3.4905 | +188.47% |
| April, 2027 | $2.3603 | $2.2203 | $4.3244 | +95.07% |
| May, 2027 | $1.03 | $0.84 | $3.0501 | -14.87% |
| June, 2027 | $2.40 | $1.14 | $3.3198 | +98.35% |
| July, 2027 | $1.1495 | $0.0702 | $2.3995 | -5.00% |
| August, 2027 | $1.368 | $0.1708 | $3.1794 | +13.06% |
| September, 2027 | $0.2516 | $0.4413 | $1.9787 | -79.20% |
| October, 2027 | $0.8421 | $0.3819 | $0.7781 | -30.40% |
| November, 2027 | $3.1726 | $1.3225 | $0.5923 | +162.20% |
| December, 2027 | $7.8233 | $4.2629 | $6.2333 | +546.55% |
Werewolf Therapeutics Inc Stock (HOWL) Price Forecast for 2028
In 2028, Werewolf Therapeutics Inc (HOWL) is projected to reach an average price of $8.154, with a high projection of $10.26 and a low estimate of $6.0481. This indicates an +573.88% rise from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.2138 | $6.6835 | $7.4538 | +578.82% |
| February, 2028 | $9.6743 | $7.8541 | $7.5043 | +699.53% |
| March, 2028 | $10.00 | $10.17 | $10.13 | +726.85% |
| April, 2028 | $9.8154 | $10.25 | $9.6053 | +711.19% |
| May, 2028 | $10.18 | $9.4656 | $9.891 | +740.99% |
| June, 2028 | $9.0265 | $9.7364 | $9.5961 | +645.99% |
| July, 2028 | $8.787 | $8.987 | $9.2668 | +626.20% |
| August, 2028 | $7.1476 | $7.7476 | $8.2373 | +490.71% |
| September, 2028 | $5.5281 | $6.0481 | $6.9329 | +356.87% |
| October, 2028 | $8.6086 | $7.3683 | $7.8986 | +611.46% |
| November, 2028 | $9.9393 | $8.9989 | $9.3843 | +721.43% |
| December, 2028 | $10.34 | $10.19 | $10.26 | +754.53% |
Werewolf Therapeutics Inc Stock (HOWL) Price Forecast for 2029
The 2029 price forecast for Werewolf Therapeutics Inc Stock (HOWL) is $8.5077 on average, with a high prediction of $10.20 and a low estimate of $6.8153. This represents an +603.11% increase from the previous price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.8204 | $10.11 | $10.20 | +711.60% |
| February, 2029 | $7.5309 | $8.0809 | $8.8705 | +522.39% |
| March, 2029 | $7.9614 | $7.891 | $7.8314 | +557.97% |
| April, 2029 | $8.9419 | $8.5017 | $8.3719 | +639.00% |
| May, 2029 | $8.2825 | $8.4525 | $8.4842 | +584.51% |
| June, 2029 | $7.673 | $7.863 | $8.2638 | +534.14% |
| July, 2029 | $6.7835 | $7.168 | $7.5933 | +460.62% |
| August, 2029 | $6.7942 | $7.0638 | $7.034 | +461.50% |
| September, 2029 | $7.1447 | $6.8544 | $6.9016 | +490.47% |
| October, 2029 | $6.7953 | $6.8153 | $7.00 | +461.59% |
| November, 2029 | $7.0908 | $6.8654 | $6.7257 | +486.02% |
| December, 2029 | $7.0163 | $7.0563 | $6.9563 | +479.86% |
Werewolf Therapeutics Inc Stock (HOWL) Price Forecast for 2030
Werewolf Therapeutics Inc Stock (HOWL) is expected to reach an average price of $5.4045 in 2030, with a high forecast of $9.89 and a low forecast of $0.9191. This signifies an +346.66% surge from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.4569 | $6.5965 | $6.3868 | +433.63% |
| February, 2030 | $5.6174 | $6.0174 | $6.167 | +364.25% |
| March, 2030 | $2.9179 | $4.4356 | $5.4575 | +141.15% |
| April, 2030 | $3.4084 | $3.558 | $3.5683 | +181.69% |
| May, 2030 | $0.8191 | $1.479 | $2.5585 | -32.31% |
| June, 2030 | $1.4196 | $0.9191 | $1.1597 | +17.32% |
| July, 2030 | $0.4502 | $1.4288 | $1.3299 | -62.80% |
| August, 2030 | $8.1402 | $0.9503 | $9.89 | +572.74% |
| September, 2030 | $7.7609 | $7.8009 | $6.5306 | +541.40% |
| October, 2030 | $8.5419 | $7.2317 | $6.6917 | +605.94% |
| November, 2030 | $7.9126 | $8.6626 | $7.5426 | +553.94% |
| December, 2030 | $9.1534 | $8.3229 | $8.4734 | +656.48% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):